Free Trial
NASDAQ:CGEN

Compugen (CGEN) Stock Price, News & Analysis

Compugen logo
$1.40 -0.07 (-4.42%)
As of 09:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Compugen Stock (NASDAQ:CGEN)

Key Stats

Today's Range
$1.40
$1.50
50-Day Range
$1.40
$1.78
52-Week Range
$1.13
$2.66
Volume
347,524 shs
Average Volume
199,621 shs
Market Capitalization
$125.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Compugen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

CGEN MarketRank™: 

Compugen scored higher than 38% of companies evaluated by MarketBeat, and ranked 644th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Compugen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Compugen has received no research coverage in the past 90 days.

  • Read more about Compugen's stock forecast and price target.
  • Earnings Growth

    Earnings for Compugen are expected to decrease in the coming year, from ($0.03) to ($0.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Compugen is -6.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Compugen is -6.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Compugen has a P/B Ratio of 2.50. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Compugen's valuation and earnings.
  • Percentage of Shares Shorted

    1.66% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Compugen has recently decreased by 2.19%, indicating that investor sentiment is improving.
  • Dividend Yield

    Compugen does not currently pay a dividend.

  • Dividend Growth

    Compugen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.66% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Compugen has recently decreased by 2.19%, indicating that investor sentiment is improving.
  • News Sentiment

    Compugen has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Compugen this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for CGEN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Compugen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.50% of the stock of Compugen is held by insiders.

  • Percentage Held by Institutions

    Only 12.22% of the stock of Compugen is held by institutions.

  • Read more about Compugen's insider trading history.
Receive CGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CGEN Stock News Headlines

Compugen (CGEN) Gets a Buy from Leerink Partners
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
Compugen Ltd. (CGEN) Q2 2025 Earnings Call Transcript
Compugen Reports Second Quarter 2025 Results
See More Headlines

CGEN Stock Analysis - Frequently Asked Questions

Compugen's stock was trading at $1.53 at the beginning of 2025. Since then, CGEN stock has decreased by 8.5% and is now trading at $1.40.

Compugen Ltd. (NASDAQ:CGEN) issued its quarterly earnings data on Wednesday, August, 6th. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.01. The biotechnology company had revenue of $1.26 million for the quarter, compared to the consensus estimate of $3.95 million. Compugen had a negative net margin of 87.45% and a negative trailing twelve-month return on equity of 34.77%.
Read the conference call transcript
.

Top institutional investors of Compugen include ARK Investment Management LLC (1.20%), Taylor Frigon Capital Management LLC (1.11%), Jane Street Group LLC (0.44%) and Rothschild Investment LLC (0.20%).

Shares of CGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Compugen investors own include Oramed Pharmaceuticals (ORMP), TransEnterix (TRXDW), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), PayPal (PYPL) and

Company Calendar

Last Earnings
8/06/2025
Today
8/29/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CGEN
CIK
1119774
Employees
70
Year Founded
1993

Price Target and Rating

High Price Target
$4.00
Low Price Target
$4.00
Potential Upside/Downside
+185.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.23 million
Net Margins
-87.45%
Pretax Margin
-67.03%
Return on Equity
-34.77%
Return on Assets
-16.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.74
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$22.14 million
Price / Sales
5.64
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.56 per share
Price / Book
2.50

Miscellaneous

Outstanding Shares
89,237,000
Free Float
80,759,000
Market Cap
$124.93 million
Optionable
Optionable
Beta
2.61

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:CGEN) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners